David Callanan
Company: Aviceda Therapeutics
Job title: CMO
Seminars:
Leveraging Clinical Data to Evaluate a Single Dose Intravitreal Administration of AVD-104 2:00 pm
Assessing the dose escalation and safety data Highlighting the benefits of using our chosen molecule Outlining the trial design for the 2 year trial with a 12 month primary endpointRead more
day: Clinical PM -Day 1
Leveraging Clinical Data to Evaluate a Single Dose Intravitreal Administration of AVD-104 3:00 pm
Assessing the dose escalation and safety data Highlighting the benefits of using our chosen molecule Outlining the trial design for the 2 year trial with a 12 month primary endpointRead more
day: Conference Day 2